In addition, the secondary follicle and antral follicle oocyte diameter was greater in the L-carnitine-supplemented group (G2) compared to the SPT group (G1)
J Clin Epidemiol 1993;46(11): 1331-6
Many patients begin noticing reduced hunger within the first few weeks, with visible weight changes developing progressively over several months
When GLP and GLP-1 receptor agonists (GLP-1 RAs, the drugs that mimic the hormone) bind to those brain receptors, the brain cells in those regions tell you that you have satisfied your need for more food, and you no longer crave it
This shift does not diminish the importance of safety, but it underscores the need to evaluate peptide systems within an appropriate therapeutic context rather than through overly conservative early-stage filters
Months 6 to 12 (maintenance and continued progress) Weight loss typically slows as the deficit narrows and the body adapts